College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Int J Dermatol. 2024 Jul;63(7):881-889. doi: 10.1111/ijd.17085. Epub 2024 Feb 23.
A filler composed of calcium hydroxylapatite and carboxymethylcellulose gel (CaHA/CMC) has been shown to possess biostimulatory and skin-tightening properties that have been applied not just to the face but also to the body to boost rejuvenation. Recently, evidence and recommendations for CaHA/CMC treatment of the face have been provided, but they are still lacking in terms of body treatment. This article aims to perform a systematic review of the literature on CaHA/CMC applications on the body and provide evidence from the literature. Currently, the only FDA-approved indication on the body is treating the hands and a recent European Union Medical Device Regulation approval has been released for decolletage treatment. The application of hyperdilutions on the neck, feet, arms, thighs, abdomen, and other body parts has been proven to provide a skin-tightening effect. However, despite their wide use with a good safety profile in clinical practice, recent trends and guidelines of diluted and hyperdiluted CaHA/CMC have yet to be supported by randomized controlled trials.
一种由羟基磷灰石和羧甲基纤维素凝胶(CaHA/CMC)组成的填充物已被证明具有生物刺激和紧致肌肤的特性,不仅可用于面部,还可用于身体,以促进年轻化。最近,已经有证据和建议表明 CaHA/CMC 可用于面部治疗,但在身体治疗方面仍然缺乏证据。本文旨在对 CaHA/CMC 在身体上的应用进行系统的文献回顾,并提供文献中的证据。目前,唯一获得 FDA 批准的身体部位应用是手部治疗,最近还发布了欧盟医疗器械法规批准用于治疗颈部。超稀释 CaHA/CMC 应用于颈部、足部、手臂、大腿、腹部和其他身体部位已被证明具有紧致肌肤的效果。然而,尽管它们在临床实践中具有良好的安全性和广泛的应用,但最近的趋势和指南表明,稀释和超稀释 CaHA/CMC 尚未得到随机对照试验的支持。